We next asked if purified SNAP-tagged NBs could enable efficient labeling of a GFP-tagged 1 3 5 membrane receptor to ultimately mediate optical control in living cells. We genetically fused GFP to 1 3 6 either the extracellular N-terminus or the intracellular C-terminus of mGluR2 (see online methods). Application of purified SNAP-tagged NBs that had been pre-labeled with Alexa-546 produced clear 1 3 8 fluorescence on the surface of HEK 293T cells expressing GFP-mGluR2, but not mGluR2-GFP ( Fig   1  3  9 2B,C; Fig S2A,B) . Importantly, following cell surface labeling with NBs, washing with buffer for 30 1 4 0 minutes did not reduce the fluorescence (Fig S2C) , indicating that the extracellular GFP-NB interaction is 1 4 1 sufficiently stable for probing signaling on the physiological timescales relevant to GPCR signaling. Many membrane receptors are oligomeric, raising the need for labeling of each subunit within a 1 4 3 complex if one is going to use NBs for efficient optical control of ligand binding with a tethered agonist. Since mGluRs are dimers in living cells [16, 17] and two agonists are required for full activation [16, 18] , 1 4 5 we sought to determine if two NBs can bind to an mGluR2 dimer. Compared to typical antibodies (~150 1 4 6 kDa), we hypothesized that the small size of NBs (~15 kDa) would decrease the chance of steric 1 4 7 hindrance between NBs on adjacent subunits. To measure the stoichiometry of SNAP-tagged NBs bound 1 4 8 1 6 5 cells with either SNAP-NB or NB-SNAP along with BGAG variants of different PEG linker length 1 6 6 (BGAG 0 , BGAG 12 , or BGAG 28 ) ( Fig. 3B) . Robust photocurrents were observed for most conditions with 1 6 7 maximal photo-activation of up to 40% relative to saturating glutamate observed for NB-SNAP with 1 6 8 BGAG 12 (Fig 3C; S3A-C) . The directionality of photoswitching, with cis-BGAG serving as an agonist, was conserved for NB conjugation to all BGAG variants as was seen in previous studies with direct 1 7 0 conjugation to an N-terminal SNAP domain [8, 10] . This supports a mechanism where relative efficacy of 1 7 1 the cis and trans configurations are due to alterations in the inherent pharmacology of the azobenzene-1 7 2 glutamate moiety, rather than the relative reach of the two forms. Importantly, in the presence of saturating (1 mM) glutamate, no photoswitching was observed indicating that BGAG 12 does not serve as a 1 7 4 partial agonist or antagonist in the NB-tethered context (Fig S3D) . Subtle differences in the BGAG length binding site. SNAP-NB showed similar efficacy with BGAG 0 and BGAG 12 whereas NB-SNAP showed a 1 7 7 2-fold increase in efficacy for BGAG 12 relative to BGAG 0 (Fig 3D) . This likely indicates that the SNAP 1 7 8 domain of SNAP-NB is, on average, closer to the glutamate binding site than the SNAP domain of NB- SNAP. Both SNAP-NB and NB-SNAP showed negligible photoswitching with BGAG 28 , consistent with tagged nanobodies relative to GFP-mGluR2 indicate distinct geometries of the two systems which could 1 8 3 account for differences in photoswitch efficacy (Fig S3E) . Protein flexibility likely also plays a major role 1 8 4 in facilitating the ability of NB-tethered BGAGs to effectively bind and activate mGluR2. This is 1 8 5 especially likely for BGAG 0 which would be too short to reach the binding site without major flexibility 1 8 6
introduced either from inter-domain linkers (i.e. between GFP and mGluR2 or SNAP and NB) or the 1 8 7 receptor itself. While the ability to target proteins for optical control using purified nanobodies opens many 1 9 2 experimental possibilities that don't require genetic manipulation, an alternative approach would take 1 9 3 advantage of the relative ease at which NBs can be genetically encoded and expressed in mammalian systems [19, 20] . Genetically encoding NBs that can then target specific proteins and provide a tethering 1 9 5 point for photoswitch attachment would allow for cell-type specific targeting, a crucial property for 1 9 6 dissecting the role of specific signaling molecules in many physiological systems, especially within the 1 9 7 circuitry of the nervous system. To see if NBs can be used to target extracellular protein domains, we 1 9 8 added an mGluR signal sequence (ss) to NB-SNAP to promote trafficking through the endoplasmic mGluR2 during the entire trafficking process (Fig 4A) . Consistent with this, co-expression of ss-NB- 4B; S4A). Co-expression of NB-SNAP, without the addition of the ss, was unable to label surface GFP-2 0 4 mGluR2 (Fig S4B) . We next tested the ability of genetically-encoded, co-expressed NB-SNAP to 2 0 5 optically control GFP-mGluR2. Similar to what was observed with purified NB-SNAP, BGAG 12 2 0 6 produced clear photocurrents that were ~20% in amplitude relative to saturating 1 mM glutamate ( Fig   2  0  7 4C). Together these data demonstrate that anti-GFP NBs may be genetically encoded to efficiently target 2 0 8 proteins for optical control. In addition to the advantage of permitting cell-type specific optical control in 2 0 9 complex systems, this approach also provides the flexibility to either label a nanobody-GFP complex for 2 1 0 optical control on the cell surface (using a membrane-impermeable photoswitch or fluorophore) or inside 2 1 1 of a cell (using a membrane-permeable photoswitch or fluorophore) to probe the distinct roles and 2 1 2 regulation of a signaling protein in different cellular locations, an increasingly appreciated aspect of In this study, we have established a new, general approach to targeting signaling proteins for 2 1 8 optical control using nanobody-photoswitch conjugates (NPCs). In contrast to a recent study using an 2 1 9 antibody to deliver an irreversible photosensitizer to inactivate AMPA receptors[23] this work establishes 2 2 0 the suitability of immunochemistry for targeting a membrane protein for reversible optical control, 2 2 1 opening the door to the manipulation of native proteins with high spatiotemporal precision. Similarly, 2 2 2 Scholler et al [24] recently reported allosteric nanobodies to manipulate mGluR2, but these tools also lack 2 2 3 reversibility and were not shown to permit genetic encoding for cell-type targeting, limiting their utility 2 2 4 for precise, dynamic manipulation of receptors. In addition, the ability of NPCs to manipulate signaling 2 2 5 via the orthosteric binding site via PORTLs permits a more physiological receptor perturbation through a 2 2 6 defined, native mechanism. Recent work has supported the idea that antibody-based approaches to manipulating GPCRs show demonstrate that NPCs can either be applied as purified complexes, which are most applicable in this 2 3 3 clinical context, or as genetically-encoded tools that can be used to target specific cell types for maximal 2 3 4 precision in mechanistic biological studies. While the ability to target NBs directly to wild-type, 2 3 5 endogenous proteins of interest offers great potential, the targeting of proteins with incorporated GFP tags 2 3 6 also offers many advantages. Strong antibodies or nanobodies with sufficient strength and specificity are 2 3 7 not available for many antigens but GFP, for which exceptionally high affinity nanobodies have been 2 3 8 developed, extensively characterized and applied in vitro and in living cells [13, 27] [28] has been 2 3 9 successfully incorporated into many proteins, often in multiple different positions, that have been well- proteins to probe their roles in physiology with optimal precision. Chemical synthesis was performed as previously described [8, 10] . Strep-tag and 10xHis-tag were cloned into a pBAD expression vector for bacterial expression, wtGFP was stored in 50 mM Hepes, 50 mM NaCl (pH 7.3) at 4 °C. mM NaCl (pH 7.3) 0.05 mg/mL BSA, 0.05% Triton X-100 in black 384-well plates (Corning, 3820). Fluorescent intensities were recorded on a Spark 20M (Tecan) with excitation at 480 nm, emission at 535 2 7 6 nm, and bandwidths of 5 nm for both excitation and emission. The dose-response was fit with Eq.1. GFP-mGluR2 in pcDNA3 was produced using standard PCR-based techniques. In brief, enhanced GFP 3 1 0 (eGFP) and a 17 amino acid glycine-rich linker were added after the mGluR2 signal sequence. HEK293T 
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